8.4 Mikroinfusionsmodus .................................................................................................................................8 - 3
8.5 Sequenz-Modus ............................................................................................................................................8 - 3
8.6 Intermittierender Modus ...........................................................................................................................8 - 4
8.7 Anlaufmodus ..................................................................................................................................................8 - 5
8.8 Dosiszeitmodus .............................................................................................................................................8 - 6
8.9 TIVA-Modus ....................................................................................................................................................8 - 6
8.10 PCA-Modus ...................................................................................................................................................8 - 7
8.11 TCI-Modus .................................................................................................................................................. 8 - 10
8.12 Lizenzen ...................................................................................................................................................... 8 - 20
9.2.1 Harte Grenzen ................................................................................................................................9 - 3
9.2.2 Weiche Grenzen ............................................................................................................................9 - 3
10 Patientenverwaltung .............................................................................................................10 - 1
11 Netzwerkkommunikation .....................................................................................................11 - 1
3